Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

199930f51dd94092baee85341.OKZIbP5ZNbg9pl2I9xcM6yn5eOJ__sPnIeP9DBoZxhA.VM57C5szZ_1LlTylhCZfjGOvG6UUv7WoGLyWWHAvpHNp7ScIyy8N4kXpLg~8c0357c2f7b7791dcc6790e483a09640
28/10/25 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/06/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/10/23 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
20/07/23 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
07/01/23 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
20/10/22 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/05/22 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/05/22 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/05/22 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/05/22 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
17/02/22 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
01/02/22 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/05/21 Amarin : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
02/02/21 Amarin : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
24/12/20 Amarin : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
08/12/20 Amarin : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- -9.42%
+23.69%
+18.14%
+54.69%
+23.66%
+23.2%
+17.29%
+9.16%
+32.94%
+66.45%
Average +25.98%
Weighted average by Cap. +26.91%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.80USD
Average target price
12.50USD
Spread / Average Target
-9.42%
High Price Target
13.00USD
Spread / Highest target
-5.80%
Low Price Target
12.00USD
Spread / Lowest Target
-13.04%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!